Your browser doesn't support javascript.
loading
Efficacy and safety of lomitapide in familial chylomicronaemia syndrome.
Cefalù, Angelo B; D'Erasmo, Laura; Iannuzzo, Gabriella; Noto, Davide; Giammanco, Antonina; Montali, Anna; Zambon, Alberto; Forte, Francesco; Suppressa, Patrizia; Giannini, Stefano; Barbagallo, Carlo M; Ganci, Antonina; Nardi, Emilio; Vernuccio, Federica; Caldarella, Rosalia; Ciaccio, Marcello; Arca, Marcello; Averna, Maurizio.
Afiliação
  • Cefalù AB; Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy.
  • D'Erasmo L; Department of Translational and Precision Medicine, "Sapienza" University of Rome, Rome, Italy.
  • Iannuzzo G; Department of Clinical Medicine and Surgery, "Federico II" University of Naples, Naples, Italy.
  • Noto D; Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy.
  • Giammanco A; Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy.
  • Montali A; Department of Translational and Precision Medicine, "Sapienza" University of Rome, Rome, Italy.
  • Zambon A; Department of Medicine - DIMED, University of Padua, Padova, Italy.
  • Forte F; Department of Clinical Medicine and Surgery, "Federico II" University of Naples, Naples, Italy.
  • Suppressa P; Department of Internal Medicine and Rare Diseases Centre "C. Frugoni", University Hospital of Bari, Bari, Italy.
  • Giannini S; Diabetology Unit, Careggi Hospital, Florence, Italy.
  • Barbagallo CM; Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy.
  • Ganci A; Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy.
  • Nardi E; Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy.
  • Vernuccio F; Section of Radiology- Department of Biomedicine, Neurosciences and Advanced Diagnostics (BiND), University Hospital "Paolo Giaccone", Palermo, Italy.
  • Caldarella R; Department of Laboratory Medicine, Unit of Laboratory Medicine, University Hospital "P. Giaccone", Palermo, Italy.
  • Ciaccio M; Department of Laboratory Medicine, Unit of Laboratory Medicine, University Hospital "P. Giaccone", Palermo, Italy; Institute of Clinical Biochemistry, Clinical Molecular Medicine and Clinical Laboratory Medicine, Department of Biomedicine, Neurosciences and Advanced Diagnostics, University of Palerm
  • Arca M; Department of Translational and Precision Medicine, "Sapienza" University of Rome, Rome, Italy.
  • Averna M; Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy; Institut of Biophysics (IBF), National Research Council CNR), Palermo, Italy. Electronic address: maurizio.averna@unipa.it.
Atherosclerosis ; 359: 13-19, 2022 10.
Article em En | MEDLINE | ID: mdl-36152419

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Benzimidazóis / Hiperlipoproteinemia Tipo I Limite: Adult / Humans Idioma: En Revista: Atherosclerosis Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Benzimidazóis / Hiperlipoproteinemia Tipo I Limite: Adult / Humans Idioma: En Revista: Atherosclerosis Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália